Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Choueiri TK, Merchán J, Patnaik A, Drakaki A, Rini BI, Rha SY, Lee JL, Ornstein MC, Kumar R, Hwang C, Shao Y, Park SH, Barata PC, McGregor BA, Foster P, Chen J, Eisen M, Cole H, Weeder B, Guan Y, Singh J, Kaplan A, Cho S, Markus R, Kabbarah O, McKay RR

Open source

DOI: 10.1038/s41586-026-10718-x
Published: 2026 Aug
Container: Nature
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41586-026-10718-x,
  title = {Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.},
  author = {Choueiri TK and Merchán J and Patnaik A and Drakaki A and Rini BI and Rha SY and Lee JL and Ornstein MC and Kumar R and Hwang C and Shao Y and Park SH and Barata PC and McGregor BA and Foster P and Chen J and Eisen M and Cole H and Weeder B and Guan Y and Singh J and Kaplan A and Cho S and Markus R and Kabbarah O and McKay RR},
  year = {2026},
  journal = {Nature},
  doi = {10.1038/s41586-026-10718-x},
  url = {https://doi.org/10.1038/s41586-026-10718-x}
}

RIS

TY  - JOUR
TI  - Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.
AU  - Choueiri TK
AU  - Merchán J
AU  - Patnaik A
AU  - Drakaki A
AU  - Rini BI
AU  - Rha SY
AU  - Lee JL
AU  - Ornstein MC
AU  - Kumar R
AU  - Hwang C
AU  - Shao Y
AU  - Park SH
AU  - Barata PC
AU  - McGregor BA
AU  - Foster P
AU  - Chen J
AU  - Eisen M
AU  - Cole H
AU  - Weeder B
AU  - Guan Y
AU  - Singh J
AU  - Kaplan A
AU  - Cho S
AU  - Markus R
AU  - Kabbarah O
AU  - McKay RR
PY  - 2026
JO  - Nature
DO  - 10.1038/s41586-026-10718-x
UR  - https://doi.org/10.1038/s41586-026-10718-x
ER  -

APA

TK, C., J, M., A, P., A, D., BI, R., SY, R., JL, L., MC, O., R, K., C, H., Y, S., SH, P., PC, B., BA, M., P, F., J, C., M, E., H, C., B, W., Y, G., J, S., A, K., S, C., R, M., O, K., & RR, M. (2026). Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.. Nature. https://doi.org/10.1038/s41586-026-10718-x

Source records

pubmed · retrieved 2026-09-26T03:36:10.812Z